9000 km/h speed, 8000 km range and…, This hypersonic missile is more powerful than BrahMos, it can evade radar, can strike entire Pakistan at once, name is… ...

Racing Victoria has announced adjustments to its protocols for international horses competing in the 2025 Spring Carnival. Among the changes is a new clause for international horses who do not hold an ...

I purchased a brand new 2024 Coachmen Remote 17R from General RV in January of 2025. It turned out to have, among other issues, a roof that is full of wrinkles.

Two authoritative reports released this year (March and June) on the growing number of the Chinese nuclear arsenal, the nuclear notebook of 2025 by the federation of American scientists (FAS) and ...

Notably, the Multiple Independently Targetable Re-entry Vehicle (MIRV) variant of Agni-V was successfully tested in Mission Divyastra (March 2024), thus proving India’s technological capability.

La Mesa RV began as a simple RV dealership in La Mesa, California, in 1972. It has since moved its headquarters to San Diego and expanded, with dealerships in Florida, Arizona and New Mexico.

NADA RV Values are now J.D. Power Values. Research used RV pricing, specs, photos, and more for everything from travel trailers to truck campers.

The K-6 missile’s Multiple Independently Targetable Reentry Vehicle (MIRV) capability further enhances its lethality. Get breaking news, in-depth analysis, and expert perspectives on everything from ...

The missile is being developed at DRDO’s Advanced Naval Systems Laboratory in Hyderabad and is specially designed for the upcoming S-5 class of nuclear submarines. Shivam Verma Updated : Jun 27, 2025, ...

On the other hand, the MIRV warhead system is far more sophisticated. MIRV-equipped missiles carry several independently guided re-entry vehicles, each capable of striking a different target with high ...

Currently, Pakistan's most advanced known missile systems—such as the Shaheen-III (range ~2,750 km) and Ababeel (with MIRV capability, range ~2,200 km)—are categorized as medium-range ballistic ...

Final data from the phase 2 PICCOLO trial (NCT05041257) demonstrated substantial efficacy in patients with folate receptor alpha (FRα)-positive recurrent platinum-sensitive ovarian cancer (PSOC) ...